Precision gene-editing company Beam Therapeutics (NASDAQ: BEAM) had a Tuesday to forget on the stock market. Following the release that morning of its latest set of quarterly results, the shares ...

Both simulations and experimental results confirm that the proposed fiber-tip microlenses effectively convert the Gaussian beam from a single-mode fiber into a dot-in-ring beam and a ring-in-ring beam ...